Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Synageva BioPharma Corp

+ Add to Watchlist

TMS1:GR

84.695 EUR 4.214 4.74%

As of 13:29:31 ET on 05/05/2015.

Snapshot for Synageva BioPharma Corp (TMS1)

Open: 88.895 Day's Range: 84.695 - 88.997 Volume: 0
Previous Close: 88.909 52wk Range: 48.340 - 110.683 1-Yr Rtn: +37.84%

Stock Chart for TMS1

No chart data available.
  • TMS1:GR 88.810
  • 1D
  • 1M
  • 1Y
88.909
Interactive TMS1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TMS1

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -7.5040
Est. PEG Ratio -
Market Cap (M EUR) 3,147.52
Shares Outstanding (M) 37.16
30 Day Average Volume 13
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 5.0000
Dividend Ex-Date 12/17/2008
5 Year Dividend Growth -
Next Earnings Announcement 07/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TMS1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TMS1

Synageva BioPharma Corp. is a clinical stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.

Sanj K PatelPresident/CEORobert Bazemore "Rob"Chief Operating Officer
Anthony G QuinnExec VP/Chief Medical OfficerCarsten BoessSenior VP/CFO
More Company Profile & Key Executives for TMS1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil